Trial Profile
Effect of RELVAR on asthma COPD overlap syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Dec 2014
Price :
$35
*
At a glance
- Drugs Vilanterol/fluticasone furoate (Primary) ; Salmeterol/fluticasone propionate
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 11 Dec 2014 Status changed from not yet recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 09 Jul 2014 New trial record